Cargando…

Treatment results of diabetic macular edema with different choroidal thickness with intravitreal anti vascular endothelial growth factor

PURPOSE: To compare the results of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy in patients with diabetic macular edema (DME) with different choroidal thicknesses. METHODS: The files of patients diagnosed with DME and treated with intravitreal anti-VEGF were reviewed retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savur, Fatma, Kaldırım, Havva, Atalay, Kürşat, Öğreden, Tülin, Hayat, Şerife Çiloğlu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773534/ https://www.ncbi.nlm.nih.gov/pubmed/36550418 http://dx.doi.org/10.1186/s12886-022-02721-3

Ejemplares similares

Comparison of Anatomical and Functional Outcomes of Intravitreal Dexamethasone Implant between Phakic and Pseudophakic Eyes with Diabetic Macular Edema
por: Kaldırım, Havva, et al.
Publicado: (2020)

Voriconazole Treatment for Fungal Chorioretinitis After Obesity Surgery
por: Savur, Fatma, et al.
Publicado: (2021)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
por: Udaondo Mirete, Patricia, et al.
Publicado: (2023)

Efficacy of Hyperbaric Oxygen Therapy on Central Corneal Thickness, Intraocular Pressure, and Nerve Fiber Layer in Patients with Type 2 Diabetes: A Prospective Cohort Study
por: Kaldırım, Havva, et al.
Publicado: (2021)

CHANGES IN SUBFOVEAL CHOROIDAL THICKNESS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT THERAPY FOR DIABETIC MACULAR EDEMA
por: Moon, Ka Young, et al.
Publicado: (2021)

Evaluation of Contrast Sensitivity after Single Intravitreal Triamcinolone Injection for Macular Edema Secondary to Branch Retinal Vein Occlusion
por: Aras Ogreden, Tulin, et al.
Publicado: (2013)

Subfoveal choroidal thickness in diabetic macular edema
por: Mohamed, Dalia Mohamed Fawzy, et al.
Publicado: (2019)

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study
por: Rishi, Pukhraj, et al.
Publicado: (2021)

Early Retinal and Choroidal Coat Thickness Changes after Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema
por: Horozoğlu, Fatih, et al.
Publicado: (2018)

Choroidal Thickness in Different Patterns of Diabetic Macular Edema
por: Amjad, Rida, et al.
Publicado: (2022)

Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema
por: Dweikat, Alaa, et al.
Publicado: (2021)

Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion
por: Aljundi, Wissam, et al.
Publicado: (2023)

Relationship between diabetic macular edema and choroidal layer thickness
por: Endo, Hiroaki, et al.
Publicado: (2020)

Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Normal Tension Glaucoma
por: Atalay, Kursat, et al.
Publicado: (2019)

Kinetics of central macular thickness reduction in patients with macular edema after intravitreal drug therapy
por: He, Lingmin, et al.
Publicado: (2011)

Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy
por: Nishide, Tadayuki, et al.
Publicado: (2013)

Intravitreal Anti-Vascular Endothelial Growth Factor for Macular Edema due to Complex Retinal Arterial Macroaneurysms
por: Bormann, Caroline, et al.
Publicado: (2017)

Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema
por: Shiraya, Tomoyasu, et al.
Publicado: (2017)

The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
por: Bae, Ki Woong, et al.
Publicado: (2022)

Choroidal Thickness Measurements in the Case of Diabetic Macular Edema. Comment on Amjad et al. Choroidal Thickness in Different Patterns of Diabetic Macular Edema. J. Clin. Med. 2022, 11, 6169
por: Marino, Andrea Valerio, et al.
Publicado: (2023)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
por: Mushtaq, Bushra, et al.
Publicado: (2014)

Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report
por: Sharma, Ashish, et al.
Publicado: (2012)

Comparison of the Effect of Ranibizumab and Aflibercept on Changes in Macular Choroidal Thickness in Patients Treated for Diabetic Macular Edema
por: Sarda, Valérie, et al.
Publicado: (2020)

Focal Laser Photocoagulation in Non-Center Involved Diabetic Macular Edema
por: Perente, Irfan, et al.
Publicado: (2014)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
por: Pessoa, Bernardete, et al.
Publicado: (2021)

Short-term Effects of Intravitreal Dexamethasone Implant on Choroidal Structure in Eyes with Refractory Diabetic Macular Edema
por: Bilici, Serdar, et al.
Publicado: (2023)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
por: Ellabban, Abdallah A, et al.
Publicado: (2012)

A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema
por: He, Ye, et al.
Publicado: (2018)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Full thickness macular hole following intravitreal ranibizumab injection for diabetic macular edema; a rare complication or coincidence?
por: Arifoglu, Hasan Basri, et al.
Publicado: (2015)

Baseline central macular thickness predicts the need for retreatment with intravitreal triamcinolone plus laser photocoagulation for diabetic macular edema
por: O’Day, Roderick, et al.
Publicado: (2013)

Choroidal Vascularity Index as a Biomarker for Visual Response to Antivascular Endothelial Growth Factor Treatment in Diabetic Macular Edema
por: Dou, Ningxin, et al.
Publicado: (2021)

Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
por: Yun, Cheolmin, et al.
Publicado: (2016)

CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
por: Hirano, Takao, et al.
Publicado: (2018)

Predictive factors for treatment outcomes with intravitreal anti-vascular endothelial growth factor injections in diabetic macular edema in clinical practice
por: Gurung, Rajya L, et al.
Publicado: (2023)

Reduced Size of Telangiectatic Capillaries After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents in Diabetic Macular Edema
por: Itou, Junichi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_98nkbj9ojt3hvftfoti3koouei